EGFR mutation, one of the most common genetic events in NSCLC, accounts for 17%–61% of lung adenocarcinoma cases reported in a series of studies, with most frequently detected in Asian, female, non-smoking patients (Kris et al., 2014; Kawaguchi et al., 2016). The gene discussed is EGFR; the disease is lung adenocarcinoma.